CC CELULARITY
DEAD

Serial Number

88641502

Owner

CELULARITY, INC.

Attorney

Camille M. Miller

Filing Date

Oct 3, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CC CELULARITY Trademark

Serial Number: 88641502

CC CELULARITY is a trademark filed by CELULARITY, INC. on October 3, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CELULARITY, INC. (50 trademarks)

33 TECHNOLOGY DRIVE
WARREN, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

October 3, 2019

Registration Date

Not Registered

Published for Opposition

March 3, 2020

Goods & Services

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use, namely, for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen

Cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells

Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; providing website featuring information in the field of medical research relating to banking stem cells and cord blood banking; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 1, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 31, 2021 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2020 EXRA
SOU EXTENSION 1 GRANTED
Oct 19, 2020 EX1G
SOU EXTENSION 1 FILED
Oct 19, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 19, 2020 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 8, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 8, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 8, 2020 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 28, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 24, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2020 CRFA
ASSIGNED TO LIE
Jan 21, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 9, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 8, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 9, 2019 NWOS
NEW APPLICATION ENTERED
Oct 7, 2019 NWAP